TD Cowen raised the firm’s price target on UnitedHealth (UNH) to $338 from $335 and keeps a Hold rating on the shares. The firm updated its model as Q3 results checked a lot of boxes; adjusted EPS beat, FY25 guide raise, tax rate/investment income inline. They raise the target but keep the P/E target unchanged.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Positive Outlook for UnitedHealth: Strong Earnings Recovery and Strategic Positioning in Value-Based Care
- UnitedHealth price target raised to $440 from $433 at Bernstein
- UnitedHealth: Navigating 2026 Challenges with Strategic Growth Plans for a Promising 2027
- Moderately bullish activity in UnitedHealth with shares down 3.11%
- RBC Capital, Leerink Analysts Boost UnitedHealth Stock (UNH) Price Targets on Q3 Beat
